Regenerative medicine - Science and Technology Committee Contents


AAT    Alliance for Advanced Therapies

ABN    Association of British Neurologists

ABPI    Association of the British Pharmaceutical Industry

ACT    Advanced Cell Technology

AIM  The London Stock Exchange's international market for smaller growing companies

AMRC  Association of Medical Research Charities

ARUK  Arthritis Research UK

ATMP  Advanced Therapy Medicinal Products

BBSRC  Biotechnology and Biological Sciences Research Council

BIA    BioIndustry Association

BIS    Department for Business, Innovation and Skills

BRCs    Biomedical Research Centres

BRUs    Biomedical Research Units

BSBMT  British Society of Blood and Marrow Transplantation

BSE    Bovine Spongiform Encephalopathy

BSH    British Society for Haematology

BSI    British Standards Institution

CAT    Committee for Advanced Therapies

CCG    Clinical Commissioning Groups

CIFs    Citizens' Innovation Funds

CIRM    California Institute for Regenerative Medicine

CRN    Clinical Research Network

DH    Department of Health

DNA    Deoxyribonucleic acid

EC    European Commission

ECJ    European Court of Justice

EFTA    European Free Trade Association

EMA    European Medicines Agency

EPSRC  Engineering and Physical Sciences Research Council

ESRC    Economic and Social Research Council

EU    European Union

FCO    Foreign and Commonwealth Office

FDA    Food and Drugs Administration

FP    Framework Programme

GB    Great Britain

GDP    Gross Domestic Product

GMP    Good Manufacturing Practice

GP    General Practitioner

GTAC  Gene Therapy Advisory Committee

HFEA    Human Fertilisation and Embryology Authority

HPA    Health Protection Agency

HRA    Health Research Authority

HTA    Human Tissue Authority

ICH    International Conference on Harmonisation

IMI    Innovative Medicines Initiative

IP    Intellectual Property

IPO    Intellectual Property Office

iPS    Induced Pluripotent Stem Cells

IRAS    Integrated Research Approval System

IVF    In Vitro Fertilisation

KCL    King's College London

KHP    King's Health Partners

KTN    Knowledge Transfer Network

LLR    Leukaemia and Lymphoma Research

LRMN  London Regenerative Medicine Network

MHRA  Medicines and HealthCare products Regulatory Agency

MRC    Medical Research Council

MS    Multiple Sclerosis

MSCs    Mesenchymal Stem Cells

NC    Non Commercial

NICE    National Institute for Health and Care Excellence

NIH    National Institutes of Health

NIHR    National Institute for Health Research

NHS    National Health Service

NHSBTS  National Health Service Blood and Transplant Service

OSCI    Oxford Stem Cell Institute

PAS    Publicly Available Specifications

PCT    Primary Care Trust

QALY    Quality Adjusted Life Year

RCPath  Royal College of Pathologists

RCUK  Research Councils UK

REMEDiE  Regenerative Medicines in Europe

RM    Regenerative Medicine

RPE    Retinal Pigment Epithelial

SC4SM  Stem Cells For Safer Medicine programme

SMEs    Small and Medium sized Enterprises

SNBTS  Scottish National Blood Transfusion Service

STFC    Science and Technology Facilities Council

TAP    Trial Acceleration Programme

TGT    Tissue Growth Technologies

TIA    Transient Ischaemic Attacks

TIC    Technology Innovation Centre

TRA    Technology Readiness Assessment

TRL    Technology Readiness Level

TSB    Technology Strategy Board

TSE    Transmissible Spongiform Encephalopathie

UCL    University College London

UKRMC  UK Regenerative Medicine Community

UKRMP  UK Regenerative Medicine Platform

UKSCF  UK Stem Cell Foundation

UKTI    UK Trade and Investment

US(A)    United States (of America)

WHO    World Health Organisation

previous page contents next page

© Parliamentary copyright 2013